lenalid 10mg capsule lenalidomide apple n.
Skip this Video
Loading SlideShow in 5 Seconds..
LENALID 10MG CAPSULE (lenalidomide ) -apple pharmaceuticals PowerPoint Presentation
Download Presentation
LENALID 10MG CAPSULE (lenalidomide ) -apple pharmaceuticals

LENALID 10MG CAPSULE (lenalidomide ) -apple pharmaceuticals

1 Vues Download Presentation
Télécharger la présentation

LENALID 10MG CAPSULE (lenalidomide ) -apple pharmaceuticals

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. LENALID 10MG CAPSULE (Lenalidomide) | Apple Pharmaceuticals LENALID 10MG Lenalid(lenalidomide ) is belongs to anticancer medication which contains Lenalidomide as an active substance which belongs to thalidomide analogue, the main ingredient which is used as lenalidomide .Lenalid 10mg is used to the disease condition by combining with dexamethasone. Lenalid 10mg (lenalidomide ) consist of some other pharmacological activities like immuno modulatory & anti-angiogenesis. Lenalid 10mg is a prescription drug that can only use under the supervision of medical oncologist. INDICATION The indications of Lenalid 10mg are; Lenalid(lenalidomide ) combination with dexamethasone is indicated to treat the patients suffered from multiple myeloma Lenalid is indicated for the patients having transfusion-dependent anemia because of intermediate 1 risk myelodysplastic syndrome along with deletion 5q cytogenetic abnormality without or without addition cytogenetic abnormalities Lenalid(lenalidomide ) is used to treat the patients with mantle cell lymphoma in which its used whose the disease was relapsed or progressed after two before treatment, especially the disease not response with the bortezomib therapy.

  2. Lenalid 10mg MECHANISM Lenalid 10mg involves in the prudence of tumor and factor alpha arrangement, that reinforcement the T-cells and leads to lessening plasma levels of cytokines vascular endothelial growth factor and fundamental fibroblast growth factor. Lenalid 10mg (lenalidomide ) is moreover engaged with the stave off angiogenesis. Lenalidomide is furthermore authorize G1 cell cycle capture and apoptosis of ruinous cells. DOSAGE The adult usual dose of Lenalid 10mg in myelodysplastic syndromes is 10mg and adminisrated once a day. For renal damaged patients; CrCl>60ml/min In Patients should not needed dosage adjustment of Lenalid 10mg (lenalidomide ) CrCl 30 to

  3. 60ml/min In Patients, 10mg of Lenalid should administre orally as once daily CrCl<30ml/min In Patient, 2.10mg of Lenalid(lenalidomide ) should be given orally as a once daily. Dosage variation; Thrombocytopenia: Drops to <50000/mcL, treatment should be interrupted. Back to > or equal to 50000/mcL, follow the Lenalid of 10mg per day. Neutropenia; Drops to <500/mcL, treatment should be delayed. Back to > or equal to 500/mcL, treatment should be follow to 10mg per day. Multiple myeloma; In this disease, concomitant use of dexamethasone with lenalid 10mg (lenalidomide ). The regular dose of Lenalid is 210mg should be given as once in a day on day 1 to 21. The dose of dexamethasone; Dexamethasone 40mg should be continued on day 1 to 4, 9 to 12 & 17 to 20 of each period of 28-day cycles. Patient with greater than 75 years, dexamethasone 20mg should be prescribed on day 1, 8, 15, & 22. PHARMACOKINETICS Absorption: absorbed rapidly withpeak plasma concentration is between 0.625 and 1.5 hrs. combining with food will not change the prolong of absorption but dose decrease in Cmax. Distribution: bounding of plasma protein is 30% Metabolism: mainly metabolized in two metabolites is hydroxy-lenalidomide and N-acetyl-lenalidomide. Excretion:

  4. primarily eliminated in renal route and the dose excreted via urine 90% and feces 4% and half-life is 3hrs MANTLE CELL LYMPHOMA The usual dose of Lenalid for this disease is 210mg should be given orally as once daily. For renal damaged patients; CrCl 30 to 60ml/min in patient, Lenalid 10mg (lenalidomide ) should be given as once daily. CrCl<30ml/min in patients, Lenalid 10mg should be used for q48hr. Pediatrics; The safety & efficiency of Lenalidomide has not been decribed in pediatric patients with age of <18 years. WARNING Venous & arterial thromboembolism Blood clotting effects Embryo fetal damage Hypersensitivity reactions Hematological disorders For all these conditions, some supportive measures should be used and provide safety measures. CONTRAINDICATION When pregnancy period the drug is contraindicated The patients are contraindicated to hypersensitivity reaction and the Lenalid 10mg (lenalidomide ) component. MISSED DOSE The missed dose of Lenalid 10mg (lenalidomide ) should be avoided. If missed dose founded, then patients should be consulting with doctor specialized in oncologist Regulate the usual dosing schedule.

  5. OVER DOSAGE Over dosage of Lenalid 10mg (lenalidomide ) will cause neutropenia & thrombocytopenia as mainly common side effects. Give the patient general supportive treatment. check the blood cells counts regularily during the treatment. SIDE EFFECTS Second primary malignancies : Hepatotoxicity , Hypersensitivity reactions, Thyroid dysfunction, Fetal toxicity, Hematological toxicity, Tumor lysis syndrome, Tumor flare reactions, Increase of mortality rate. Common side effects; Diabetes mellitus, Rash, Insomnia, Depression, Deep vein thrombosis, Myocardial infraction, Renal failure, Squamous cell carcinoma, Basal cell carcinoma, Fatigue, Asthenia, Pyrexia, Pain, Diarrhea, Dyspepsia, Bone pain, Neck pain, Respiratory infections, UTI, Influenza, Sepsis, Headache, Anemia, Loss of appetite, Hypokalemia, Hyperglycemia, Hypocalcaemia, Dehydration, Gout. CONTACTS Phone : +91- 9987711567 Email: WEBSITE: